Login

Iterum Therapeutics plc 4 SEC Filings

Filed On Filing
20 Nov 2025 Form 4: Dunne Michael W., Director

Bought 6,000 shares ($2.19K)

12 Aug 2025 Form 4: Dunne Michael W., Director

Bought 15,000 shares ($10.9K)

03 Jul 2025 Form 4: Coyne Christine, Chief Commercial Officer

Granted 200,000 Share Option (Right to Buy)

23 Jan 2025 Form 4: Hunt Ronald, Director

Disposed of 0 6.500% Exchangeable Senior Subordinated Note due 2025 (Other Transaction)

12 Aug 2024 Form 4: Dunne Michael W., Director

Received 106,247 shares by exercise or conversion · Acquired 212,494 Warrants (right to buy) (Option Exercise/Conversion)

12 Aug 2024 Form 4: Fishman Corey N., Director

Received 82,613 shares by exercise or conversion · Acquired 165,226 Warrants (right to buy) (Option Exercise/Conversion)

12 Aug 2024 Form 4: Hunt Ronald, Director

Received 247,934 shares by exercise or conversion · Acquired 495,868 Warrants (right to buy) (Option Exercise/Conversion)

27 Dec 2023 Form 4: Dunne Michael W., Director

Bought 25,000 shares ($35K)

19 Dec 2023 Form 4: Dunne Michael W., Director

Bought 10,000 shares ($18.4K)

04 Dec 2023 Form 4: Puttagunta Sailaja, Chief Medical Officer

Received 8,333 shares as a grant or award · Gave up 2,933 shares to cover exercise price or tax ($6.22K) · Exercised 8,333 Restricted Share Units

27 Nov 2023 Form 4: Dunne Michael W., Director

Bought 20,000 shares ($40.7K)

20 Nov 2023 Form 4: Fishman Corey N., Director

Bought 10,000 shares ($15.9K)

02 Oct 2023 Form 4: Hunt Ronald, Director

Received 5,479 shares by exercise or conversion

02 Oct 2023 Form 4: Dunne Michael W., Director

Received 3,487 shares by exercise or conversion

03 Jul 2023 Form 4: Dunne Michael W., Director

Received 1,779 shares by exercise or conversion

03 Jul 2023 Form 4: Hunt Ronald, Director

Received 2,796 shares by exercise or conversion

15 Jun 2023 Form 4: Hecht Beth, Director

Received 15,853 shares by exercise or conversion

15 Jun 2023 Form 4: Dunne Michael W., Director

Received 15,853 shares by exercise or conversion

15 Jun 2023 Form 4: Chin Mark, Director

Received 15,853 shares by exercise or conversion

03 Apr 2023 Form 4: Hunt Ronald, Director

Received 2,041 shares by exercise or conversion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support